U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06891092) titled 'Vivinex Impress XY1-EM vs RayOne EMV' on March 17.
Brief Summary: Comparison of the outcomes of bilateral implantation of extended depth of vision (EDOF) intraocular lenses (IOLs): the Rayone EMV and the Vivinex Impress XY1-EM in patients with cataract
Study Start Date: June 01, 2025
Study Type: INTERVENTIONAL
Condition:
Cataract
Intervention:
DEVICE: RayOne EMV
non-diffractive monofocal IOL
DEVICE: Vivinex Impress
non-diffractive monofocal IOL
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Medical University of Bialystok
Published by HT Digital Content Services with permission from Health Daily Digest....